Display search results for ** instead (50 products)

Showing 1-10 of 50

This issue depicts the current landscape and the new trends in a series of developments associated with gene therapy and neurodegenerative diseases. The first part of the study focuses on research collaborations between innovative pharmaceutical companies, whereas the second part is mostly centered on innovation and technology management. An append...

USD 250.00

USD 187.50 save 25 %

This issue depicts the current landscape and the new trends in a series of developments associated with Alzheimer’s disease. The study is focused on biomarker diagnostics, starting with the enumeration of the principal trends in biomarker diagnostics for Alzheimer’s disease. Cutting-edge technologies including a novel immunoassay for Alzheimer...

USD 250.00

USD 187.50 save 25 %

This technology opportunity engine (TOE) service depicts the current landscape and the new life sciences trends across EU5 (Germany, France, Italy, Spain, and UK). The study is focused on DNA-based drug solutions for oncological and infectious diseases, as well as, innovations in cell therapy by evaluating approvals in stem cell-based therapies, an...

USD 250.00

USD 187.50 save 25 %

This technology opportunity engine (TOE) service, Genetic Technology News, depicts the current landscape and the new life sciences trends across drug discoveries accelerated through protein-based techniques. Special emphasis has been focused on life sciences research through 3D images of megaenzymes and bispecific antibodies, as well as, research...

USD 250.00

USD 187.50 save 25 %

04 Feb 2016  |  Global

Vital Signs - Spiraling US Drug Costs, Wearable Healthcare Technologies and the Zika Virus, An Analysis

Urgent Remedial Action Required as Nearly 1/4th US Prescription Drug Users Find it Difficult to Afford their Prescriptions

This issue of Vital Signs discusses why the US pays more than other countries for drugs, the inside story on wearable electronics, the spreading Zika virus, and soaring US drug costs.

USD 450.00

USD 337.50 save 25 %

This edition of Genetic Technology depicts the current landscape and the new life sciences trends across multiplex proteomics techniques. The current issue makes reference to novel probe technologies for proteomic analyses from several companies, as well as nanotech-based assays for next generation proteomics. Keywords: Multiplex proteomics techn...

USD 250.00

USD 187.50 save 25 %

12 Feb 2016  |  Global

Vital Signs - Impact of Strategic Acquisitions on Life Sciences Market, 2016

Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories

This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.

USD 450.00

USD 337.50 save 25 %

This edition of Genetic Technology depicts the current landscape and the new life sciences trends across schizophrenia and other central nervous system (CNS) disorders. Specific products developed to target chronic CNS disorders, including the use of cell therapeutics and autoimmune approaches, are profiled. Additionally, analyst insights and stra...

USD 250.00

USD 187.50 save 25 %

This edition of Genetic Technology TechVision Opportunity Engine (TOE), depicts the current landscape and the new life sciences trends across neuroinformatic innovations In Europe. International platforms associated with neuroinformatics developments are studied, including neurodiagnostics, machine learning approaches, and neuroimaging, among other...

USD 250.00

USD 187.50 save 25 %

This edition of the Genetic Technology Technology Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing mechanisms and cell therapies. The study covers the institutions involved in the CRISPR patent battle and the licensing agree...

USD 250.00

USD 187.50 save 25 %

Showing 1-10 of 50